DEBx Medical, an Amsterdam, Netherlands-based medical devices company, received €10M in funding.
TVM Capital Healthcare made the investment. As part of the firm’s investment, DEBx Medical will establish a regional headquarter and a production base in MENA, thereby accelerating the introduction of its innovative wound care solution to the region.
The company intends to use the funds to expand its global footprint and build a presence in the MENA region.
Founded in 2019 by CEO Bert Quint, Prof. Dr. Carlo Bignozzi and MD Alberto Cogo, DEBx Medical is a medical technology company dedicated to managing chronic wounds by enabling them to heal, thereby improving outcomes. They developed DEBRICHEM®, which offers an alternative to existing treatments for non-healing chronic wounds. The product is intended for topical application to an infected non-healing wound, to eliminate infection by removing biofilm and by this infection, then followed by cleaning and dressing.
With CE and ISO approvals obtained in February 2021, DEBx Medical has already treated over 5,000 patients, and is about to introduce its product to the market.
FinSMEs
22/05/2023